Swiss pharma firm Sandoz to pay $450 million in US antitrust suit

· swissinfo.ch

Swiss pharma firm Sandoz will pay $478.5M to settle US generic drug price-fixing claims while denying wrongdoing.

Swiss pharma firm Sandoz to pay $450 million in US antitrust suit

Sandoz to pay $450 million following a settlement with 43 US states Keystone-SDA

Sandoz has ...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI